These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 10023501)

  • 1. Concentrations of 3 alpha-reduced neuroactive steroids and their precursors in plasma of patients with major depression and after clinical recovery.
    Ströhle A; Romeo E; Hermann B; Pasini A; Spalletta G; di Michele F; Holsboer F; Rupprecht R
    Biol Psychiatry; 1999 Feb; 45(3):274-7. PubMed ID: 10023501
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of antidepressant treatment on neuroactive steroids in major depression.
    Romeo E; Ströhle A; Spalletta G; di Michele F; Hermann B; Holsboer F; Pasini A; Rupprecht R
    Am J Psychiatry; 1998 Jul; 155(7):910-3. PubMed ID: 9659856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluoxetine decreases concentrations of 3 alpha, 5 alpha-tetrahydrodeoxycorticosterone (THDOC) in major depression.
    Ströhle A; Pasini A; Romeo E; Hermann B; Spalletta G; di Michele F; Holsboer F; Rupprecht R
    J Psychiatr Res; 2000; 34(3):183-6. PubMed ID: 10867112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma concentrations of neuroactive steroids before and after repetitive transcranial magnetic stimulation (rTMS) in major depression.
    Padberg F; di Michele F; Zwanzger P; Romeo E; Bernardi G; Schüle C; Baghai TC; Ella R; Pasini A; Rupprecht R
    Neuropsychopharmacology; 2002 Nov; 27(5):874-8. PubMed ID: 12431862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Panic induction with cholecystokinin-tetrapeptide (CCK-4) Increases plasma concentrations of the neuroactive steroid 3alpha, 5alpha tetrahydrodeoxycorticosterone (3alpha, 5alpha-THDOC) in healthy volunteers.
    Eser D; di Michele F; Zwanzger P; Pasini A; Baghai TC; Schüle C; Rupprecht R; Romeo E
    Neuropsychopharmacology; 2005 Jan; 30(1):192-5. PubMed ID: 15467707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma concentrations of neuroactive steroids before and after electroconvulsive therapy in major depression.
    Baghai TC; di Michele F; Schüle C; Eser D; Zwanzger P; Pasini A; Romeo E; Rupprecht R
    Neuropsychopharmacology; 2005 Jun; 30(6):1181-6. PubMed ID: 15702138
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of sleep deprivation on neuroactive steroids in major depression.
    Schüle C; di Michele F; Baghai T; Romeo E; Bernardi G; Zwanzger P; Padberg F; Pasini A; Rupprecht R
    Neuropsychopharmacology; 2003 Mar; 28(3):577-81. PubMed ID: 12629540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of mirtazapine on plasma concentrations of neuroactive steroids in major depression and on 3alpha-hydroxysteroid dehydrogenase activity.
    Schüle C; Romeo E; Uzunov DP; Eser D; di Michele F; Baghai TC; Pasini A; Schwarz M; Kempter H; Rupprecht R
    Mol Psychiatry; 2006 Mar; 11(3):261-72. PubMed ID: 16344854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroactive steroid concentrations following metyrapone administration in depressed patients and healthy volunteers.
    Rupprecht R; Ströhle A; Hermann B; di Michele F; Spalletta G; Pasini A; Holsboer F; Romeo E
    Biol Psychiatry; 1998 Nov; 44(9):912-4. PubMed ID: 9807647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroactive steroids in responders and nonresponders to sleep deprivation.
    Schüle C; Di Michele F; Baghai T; Romeo E; Bernardi G; Zwanzger P; Padberg F; Pasini A; Rupprecht R
    Ann N Y Acad Sci; 2004 Dec; 1032():216-23. PubMed ID: 15677414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased neuroactive steroid concentrations in women with bipolar disorder or major depressive disorder.
    Hardoy MC; Serra M; Carta MG; Contu P; Pisu MG; Biggio G
    J Clin Psychopharmacol; 2006 Aug; 26(4):379-84. PubMed ID: 16855455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sensitization of gamma-aminobutyric acidA receptors to neuroactive steroids in rats during ethanol withdrawal.
    Devaud LL; Purdy RH; Finn DA; Morrow AL
    J Pharmacol Exp Ther; 1996 Aug; 278(2):510-7. PubMed ID: 8768698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mirtazapine does not influence tetrahydrodeoxycorticosterone levels in depressed patients.
    Schüle C; Baghai TC; di Michele F; Eser D; Pasini A; Romeo E; Rupprecht R
    World J Biol Psychiatry; 2010 Mar; 11(2 Pt 2):308-13. PubMed ID: 20218794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Longitudinal proneuroactive and neuroactive steroid profiles in medication-free women with, without and at-risk for perinatal depression: A liquid chromatography-tandem mass spectrometry analysis.
    Deligiannidis KM; Kroll-Desrosiers AR; Tan Y; Dubuke ML; Shaffer SA
    Psychoneuroendocrinology; 2020 Nov; 121():104827. PubMed ID: 32828068
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of combination treatment with mood stabilizers and mirtazapine on plasma concentrations of neuroactive steroids in depressed patients.
    Schüle C; Baghai TC; di Michele F; Eser D; Pasini A; Schwarz M; Rupprecht R; Romeo E
    Psychoneuroendocrinology; 2007 Jul; 32(6):669-80. PubMed ID: 17560730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relevance of endogenous 3alpha-reduced neurosteroids to depression and antidepressant action.
    Uzunova V; Sampson L; Uzunov DP
    Psychopharmacology (Berl); 2006 Jun; 186(3):351-61. PubMed ID: 16249906
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between omega-3 fatty acids and plasma neuroactive steroids in alcoholism, depression and controls.
    Nieminen LR; Makino KK; Mehta N; Virkkunen M; Kim HY; Hibbeln JR
    Prostaglandins Leukot Essent Fatty Acids; 2006; 75(4-5):309-14. PubMed ID: 16959481
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term treatment with clozapine does not affect morning circulating levels of allopregnanolone and THDOC in patients with schizophrenia: a preliminary study.
    Monteleone P; Fabrazzo M; Serra M; Tortorella A; Pisu MG; Biggio G; Maj M
    J Clin Psychopharmacol; 2004 Aug; 24(4):437-40. PubMed ID: 15232336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroactive steroids in depression and anxiety disorders: clinical studies.
    Eser D; Schüle C; Baghai TC; Romeo E; Rupprecht R
    Neuroendocrinology; 2006; 84(4):244-54. PubMed ID: 17159334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induced panic attacks shift gamma-aminobutyric acid type A receptor modulatory neuroactive steroid composition in patients with panic disorder: preliminary results.
    Ströhle A; Romeo E; di Michele F; Pasini A; Hermann B; Gajewsky G; Holsboer F; Rupprecht R
    Arch Gen Psychiatry; 2003 Feb; 60(2):161-8. PubMed ID: 12578433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.